AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $192,000 | -41.5% | 24,969 | -47.8% | 0.05% | -33.3% |
| Q2 2019 | $328,000 | +6.5% | 47,864 | +25.1% | 0.07% | +7.5% |
| Q1 2019 | $308,000 | +7.3% | 38,264 | 0.0% | 0.07% | -15.2% |
| Q4 2018 | $287,000 | -66.7% | 38,264 | -57.5% | 0.08% | -52.4% |
| Q3 2018 | $862,000 | -46.3% | 90,099 | -40.6% | 0.17% | -48.9% |
| Q2 2018 | $1,606,000 | – | 151,781 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |